Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Deorphanization and characterization of human olfactory receptors in heterologous cells.

Chatelain P, Veithen A, Wilkin F, Philippeau M.

Chem Biodivers. 2014 Nov;11(11):1764-81. doi: 10.1002/cbdv.201400083.

PMID:
25408322
2.

Profiling of olfactory receptor gene expression in whole human olfactory mucosa.

Verbeurgt C, Wilkin F, Tarabichi M, Gregoire F, Dumont JE, Chatelain P.

PLoS One. 2014 May 6;9(5):e96333. doi: 10.1371/journal.pone.0096333. eCollection 2014.

3.

Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells.

Bar I, Guns PJ, Metallo J, Cammarata D, Wilkin F, Boeynams JM, Bult H, Robaye B.

Mol Pharmacol. 2008 Sep;74(3):777-84. doi: 10.1124/mol.108.046904. Epub 2008 Jun 3.

PMID:
18523137
4.

Loss of nucleotide regulation of epithelial chloride transport in the jejunum of P2Y4-null mice.

Robaye B, Ghanem E, Wilkin F, Fokan D, Van Driessche W, Schurmans S, Boeynaems JM, Beauwens R.

Mol Pharmacol. 2003 Apr;63(4):777-83.

PMID:
12644577
5.
6.

The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells.

Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B.

J Immunol. 2001 Jun 15;166(12):7172-7.

7.

Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.

Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):377-84.

8.

Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.

Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, Hudson T, Stampfer M, Pollak M.

J Clin Endocrinol Metab. 2001 Mar;86(3):1274-80.

PMID:
11238520
9.

Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease.

Mircescu H, Wilkin F, Paquette J, Oligny LL, Decaluwe H, Gaboury L, Nolet S, Van Vliet G, Deal C.

J Pediatr. 2001 Feb;138(2):269-73.

PMID:
11174629
10.

H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels.

Wilkin F, Paquette J, Ledru E, Hamelin C, Pollak M, Deal CL.

Eur J Biochem. 2000 Jul;267(13):4020-7. Erratum in: Eur J Biochem 2000 Aug;267(15):4901. Mamelin C [corrected to Hamelin C].

11.

Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.

Wilkin F, Gagné N, Paquette J, Oligny LL, Deal C.

J Clin Endocrinol Metab. 2000 May;85(5):2048-56. Review.

PMID:
10843195
12.

Characterization of a phosphoprotein whose mRNA is regulated by the mitogenic pathways in dog thyroid cells.

Wilkin F, Suarez-Huerta N, Robaye B, Peetermans J, Libert F, Dumont JE, Maenhaut C.

Eur J Biochem. 1997 Sep 15;248(3):660-8.

13.

The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesis.

Uyttersprot N, Allgeier A, Baptist M, Christophe D, Coppee F, Coulonval K, Deleu S, Depoortere F, Dremier S, Lamy F, Ledent C, Maenhaut C, Miot F, Panneels V, Parma J, Parmentier M, Pirson I, Pohl V, Roger P, Savonet V, Taton M, Tonacchera M, van Sande J, Wilkin F, Vassart G, et al.

Adv Second Messenger Phosphoprotein Res. 1997;31:125-40. Review. No abstract available.

PMID:
9344247
14.

Identification and characterization of novel genes modulated in the thyroid of dogs treated with methimazole and propylthiouracil.

Wilkin F, Savonet V, Radulescu A, Petermans J, Dumont JE, Maenhaut C.

J Biol Chem. 1996 Nov 8;271(45):28451-7.

15.

Cloning of cDNA specifically involved in the thyroid cAMP mitogenic pathway.

Miot F, Wilkin F, Dremier S, Uyttersprot N, Lamy F, Dumont JE, Maenhaut C.

Horm Res. 1994;42(1-2):27-30. Review.

PMID:
7959630
16.

Supplemental Content

Loading ...
Support Center